A weekly programme that illuminates the mysteries and challenges the controversies behind the science that's changing our world.

Kim Kelderman; Chief Executive Officer, Chief Operating Officer, Director; Bio-Techne Corp James Hippel; Chief Financial Officer, Executive Vice President - Finance; Bio-Techne Corp Good morning, and ...

Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Second Quarter of Fiscal Year 2025. At this time, all participants have been placed in a listen-only mode and the call will ...

Solid +5.1% Growth in a Challenging Context Record Results, Reaching 20% Operating Margin Sales: 43.48 billion euros, +5.6% reported and +5.1% like-for-like1. Another year of outperformance in a norma ...